Innovations in Precision Medicine, Cell Therapies, Vaccines, Gene Therapy, 3D Bioprinting and Alzheimer’s Treatment

Share this:
Published: 19 Apr 2019

The Life Science, Health & Wellness TechVision Opportunity Engine (TOE) comprises analytical insights across global innovations in cell therapy, biomanufacturing precision medicine, PCR, solid dose formulations, diagnostics, 3D bioprinting, vaccines, and biologics platforms. The Life Science, Health & Wellness TOE will feature disruptive technology advances in the global life sciences industry. The technologies and innovations profiled will encompass developments across genetic engineering, drug discovery and development, biomarkers, tissue engineering, synthetic biology, microbiome, disease management, as well as health and wellness among several other platforms. The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare. Keywords: Precision medicine, cell therapies, vaccines, gene therapy, 3D bioprinting, Alzheimer’s treatment, immuno-oncology, neurodegeneration, Parkinson’s disease, biologics, PCR, diagnostics, p53, immunogenic peptides, nanoparticles



Features of this research


Help Desk

Full list of offices

For more information and general enquiries, contact Frost & Sullivan near you.

North America
tel: +1.877.463.7678

Select a location near you..